Supira Medical develops a low-profile, high continuous flow percutaneous ventricular assist device for high-risk coronary intervention and cardiogenic shock patients.
TEKEVER's programme ceiling is up to £400 million over ten years, so revenue per aircraft cannot be computed; fleet size and the support TEKEVER carries set the conditions for value capture. The AR5 was selected to replace the ageing Watchkeeper drones, and on 24 July 2026 the Ministry of Defence published a transparency notice announcing a direct award to TEKEVER for Project CORVUS, with the notice not the contract itself.
The initial order will be for six AR5 drones, with up to 24 delivered by 2029. Subject to contract signature and final approvals, TEKEVER will support the capability for an initial period of at least five years, with options to extend. CORVUS will anchor TEKEVER's growing UK sovereign capability across engineering, manufacturing, training and operational support.
